Allergan Aesthetics Publishes ‘The Future of Aesthetics’
Report aims to help support the evolving needs of patients
Read MoreReport aims to help support the evolving needs of patients
Read MoreAbbVie and Allergan Aesthetics announced today that more than 30 abstracts, including seven podium presentations, will be presented during the upcoming TOXINS 2022 Conference, July 27-30 in New Orleans. Clinical...
Read MoreAllergan, a leading global biopharmaceutical company, announced that the company has suspended sales of textured breast implants and tissue expanders and is withdrawing any remaining supply in European markets. The...
Read MoreAllergan plc announced that the CoolSculpting® treatment received FDA clearance to treat the submandibular area. In addition, the FDA clearance was expanded to include patients with a BMI of up to 46.2 when...
Read MoreAllergan plc, announced during the 16th Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monte Carlo, Monaco, results of its latest global survey, The Importance of Trust in Beauty, investigating the role...
Read MoreAllergan plc announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market NATRELLE INSPIRA® SoftTouch breast implants, offering women undergoing breast reconstruction, augmentation or...
Read MoreAllergan plc announced the company has received approval from the U.S. Food and Drug Administration (FDA) to market NATRELLE INSPIRA® Cohesive breast implants, offering women undergoing reconstruction, augmentation or revision...
Read MoreAllergan plc, a leading global pharmaceutical company, announced that it has acquired Topokine Therapeutics, a privately held, clinical-stage biotechnology company focused on developing topical medicines for fat reduction. Under...
Read More